Diagnostic Imaging Care

The Newest Ways to See Exactly What We Are Treating and Why

Tests and Care

Diagnostic Technology has dramatically changed over the years. Cancer Partners stays at the forefront of innovation, incorporating the latest imaging advancements into our care.

  • Since 2005, Cancer Partners has held continuous PET and CT ACR accreditations
  • Cancer Partners had the first fixed PET/CT scanner in Lincoln, Nebraska, accredited by the American College of Radiology (ACR)
  • Meeting and exceeding quality assurance and safety guidelines is our top priority

PET

(Positron Emission Tomography)

This imaging gauges the severity and spread of cancer. PET scans can give physicians a way to detect cancer early and in more treatable stages – sometimes months before a tumor becomes evident through other forms of diagnostic testing. Cancer Partners was one of the first clinics in Nebraska to incorporate PET techniques into our cancer care.

F-18 FDG: Oncology

This injection is used to detect metabolically-active lesions among several different types of cancers. It is the most common radiotracer used in PET imaging.

F-18 Sodium Fluoride: Bone

This is a radioactive substance that is injected into the vein to find out if cancer has spread to the bone.

Axumin: Prostate

This radioactive substance is injected in men with suspected prostate cancer recurrence. If you have elevated PSA levels following prior treatment, then an Axumin PET scan may detect recurrent disease.

Gallium 68 Dotatate: Neuroendocrine

This is a radioactive substance that is injected during a PET scan to help evaluate primary and metastatic neuroendocrine tumors.

Copper 64 Dotatate: Neuroendocrine

This is a recent FDA-approved radioactive substance that is injected during a PET scan to help evaluate primary and metastatic neuroendocrine tumors. It has high sensitivity and specificity in patients, which leads to better detection for tumor restaging purposes.

CT

(Computed Tomography)

CT scans produce detailed, cross-sectional images of the inside of the body. Cancer Partners offers general CT scans, in addition to lung screening.

Additional Therapies

Radium-223 XOFIGO: Prostate

This medication is combined with a radioactive substance and is used to treat prostate cancer that no longer responds to hormonal or surgical treatment.

Lutetium-177 Dotatate: Neuroendocrine

This is a breakthrough, radioactive injection that is used to treat certain types of neuroendocrine tumors in patients whose cancer has not responded well to other treatments.

Zevalin Y90: Non-Hodgkin’s Lymphoma

This medication is combined with a radioactive substance and used along with rituximab to treat B-cell non-Hodgkin’s follicular lymphoma in patients whose cancer has returned or has not responded to other treatments.

Samarium 153: Bone

This radioactive substance is injected in patients to help relieve bone pain in patients with bone cancer and other cancers that have spread to the bone.

Our Certifications

The ACR Gold Standard of Accreditation

Cancer Partners has voluntarily gone through a rigorous review process to make sure we meet and exceed nationally accepted standards of care.

Every aspect of the ACR accreditation process is overseen by board-certified, expert radiologists and medical physicists in advanced diagnostic imaging.

ACR CT

  • ACR Certification – PET/CT
  • ACR Certification – CT – head/neck/chest
Call Us to Learn More

Frequently Asked Questions

What does ACR accreditation mean?

Our facility has voluntarily gone through a rigorous review process to ensure that we meet nationally accepted standards of care.

Our personnel is well qualified, through education and certification, to perform medical imaging, interpret your images and administer your radiation therapy treatments.

Our equipment is appropriate for the test or treatment you will receive, and our facility meets or exceeds quality assurance and safety guidelines.

What does the gold seal mean?

When you see the ACR gold seal, you can be assured that your prescribed imaging test will be done at a facility that has met the highest level of imaging quality and radiation safety. The facility and its personnel have gone through a comprehensive review to earn accreditation status by the American College of Radiology (ACR), the largest and oldest imaging accrediting body in the United States and a professional organization of 34,000 physicians.

The first effective PET/CT scan for prostate cancer patients in Nebraska was completed at Cancer Partners.

Request an Appointment

Let’s set a time to talk.

Request an appointment by phone or online.

Contact Us
To Top